How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

ID

SWX:Idorsia
Get a brief AI stock analysisSaves ~ 15 minutes of your time

ID

Idorsia LtdSWX Idorsia Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XSWX - Six Swiss Exchange

FAIR VALUE

Is IDIA undervalued compared to its fair value?

The fair value of IDIA stock is hidden CHF. Relative to the market price of 2.278 CHF Idorsia Ltd is hidden.

Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft...[More about valuation]

Idorsia Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.477 $B

Price:

2.278 CHF

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.128

FINANCIALS

Idorsia financial for reporting period

Income Statement

0.01 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.094 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.03 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.01 B 100%
0.0065 B 65%
-0.094 B -932%
0.03 B 297%

Balance Sheet

0.78 B
-0.94 B


Financial Position Analysis

Assets

0.78 B
Current Assets
0.48 B
Total non-current assets
0.31 B

Total current liabilities
0.42 B
Total non-current liabilities
1.3 B

Cash Flow Statement

-0.12 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.12 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Idorsia fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-163 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-9 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is IDIA attractive for investment based on fundamental analysis?

IDIA stock rating is hidden. Idorsia is a hidden by Eyestock methodology.

Get IDIA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-40

Gross Margin:

93

CFO / Debt ratio:

hidden

Current ratio:

1.12

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

IDIA.SW analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for IDIA.SW to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Idorsia Ltd competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Idorsia Ltd dividends

IDIA.SW dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About IDIA.SW stock

About the company Idorsia Ltd

Market cap $B

0.477

Dividend yield

Shares outstanding

187.559 B

Idorsia Ltd. operates as a biopharmaceutical firm which focuses on discovery, development and commercialization of innovative medicines for unmet medical needs. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2017-06-16. The firm will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The firm's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

IDIA.SW profile

  • Ticker

    IDIA.SW

  • Country

    Switzerland

  • Exchange

    XSWX - Six Swiss Exchange

  • Report currency

    CHF - Swiss franc

  • IPO date

    16 June 2017

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

  • City

    Allschwil

  • Address

    Hegenheimermattweg 91

  • Cusip

    H3879B109